|Day Low/High||61.39 / 62.36|
|52 Wk Low/High||57.80 / 77.50|
The most recent short interest data has been released for the 08/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
- Inside Rx adds 18 new products to discount list, including acne, anti-inflammatory eye care, asthma, COPD, dermatitis, diabetes, and psoriasis.
U.S. stock futures turn higher on Tuesday following earnings from Alphabet.
Wall Street's first glimpse at the second quarter.
Jim Cramer points out the positive actions that show how rallies can come together based on fundamentals, not just sentiment.
Jim Cramer notes Starbucks is improving its mobile ordering and pay experience.
One Wall Street firm thinks it's a real possibility.
But, Walgreens says Amazon probably won't pursue this venture.
Here's what you need to know now.
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
Everything you must know about the market right now is here.
Jim Cramer says the story is less about Comey vs. Trump than it is about Nvidia vs. Nordstrom.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is bringing back his "CANDIES" market acronym.
I was pleasantly surprised to see that the candies are still crushing it.
The CDC estimates that 90 people a day die from opioid overdoses.
Amazon Pharmacy could radically disrupt the generic drug business.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.